Nanostring Cancer Immune Panel Pre and Post ETC-159
Ontology highlight
ABSTRACT: Tumor specimen samples from the multi-site, international, phase I advanced solid tumor ETC-159 clinical trial (NCT02521844, A*STAR Research Entities, Singapore), were analyzed using the PanCancer IO panel
ORGANISM(S): Homo sapiens
PROVIDER: GSE167039 | GEO | 2021/02/19
REPOSITORIES: GEO
ACCESS DATA